INTEGRATIVE MODEL OF SUBCELL PROCESSES: APPL TO SYNAPTIC ACT & PHARM DISCOVERY
子细胞过程的整合模型:应用于突触行为
基本信息
- 批准号:7601639
- 负责人:
- 金额:$ 53.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-05-01 至 2008-04-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcetylcholinesteraseCholinergic ReceptorsChromosome PairingComputer Retrieval of Information on Scientific Projects DatabaseComputer softwareDiffusionDiseaseElectrostaticsFundingGrantInstitutionKineticsMalignant NeoplasmsMechanicsMethodsModelingNeurologicPharmacologic SubstanceProcessResearchResearch PersonnelResourcesSourceSynapsesUnited States National Institutes of Healthdrug discoverymolecular modelingnovelsimulationtheories
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Multiscale simulation methods are being created and applied to the study of synaptic activity and the discovery of new pharmaceuticals. For synaptic activity, the simulations include QM/MM studies of acetylcholinesterase (AChE), analysis of the kinetics of AChE and the activity of ACh receptors, and integrated analyses of all of these components in model synapses. These simulations depend on novel theory and software for molecular modeling, including advanced methods for the modeling of electrostatics, diffusion, mechanics, and hydrodynamics at the supramolecular scale. These same methods are used in novel ways to facilitate discovery of drugs for neurologic diseases, and for other diseases including HIV/AIDS and cancer.
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
正在创建多尺度模拟方法,并将其应用于突触活动的研究和新药的发现。在突触活动方面,模拟包括对乙酰胆碱酯酶(AChE)的QM/MM研究,AChE动力学和ACh受体活性的分析,以及对模型突触中所有这些成分的综合分析。这些模拟依赖于分子建模的新理论和软件,包括在超分子尺度上对静电学、扩散、力学和流体动力学进行建模的先进方法。这些同样的方法也被用在新的方式上,以促进发现治疗神经系统疾病以及包括艾滋病毒/艾滋病和癌症在内的其他疾病的药物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES ANDREW MCCAMMON其他文献
JAMES ANDREW MCCAMMON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES ANDREW MCCAMMON', 18)}}的其他基金
BUILDING COMPLEXITY INTO THE COMPUTER-AIDED DRUG DESIGN PIPELINE THROUGH
通过增加计算机辅助药物设计流程的复杂性
- 批准号:
8362794 - 财政年份:2011
- 资助金额:
$ 53.46万 - 项目类别:
MOLECULAR FLEXIBILITY IN DRUG DESIGN USING MICROSECOND MOLECULAR DYNAMICS
利用微秒分子动力学的药物设计中的分子灵活性
- 批准号:
8364206 - 财政年份:2011
- 资助金额:
$ 53.46万 - 项目类别:
TOWARD DEVELOPING NEW ANTIVIRALS AGAINST AVIAN INFLUENZA MEMBRANE GLYCOPROTEINS
致力于开发针对禽流感膜糖蛋白的新型抗病毒药物
- 批准号:
8362795 - 财政年份:2011
- 资助金额:
$ 53.46万 - 项目类别:
MOD THE STRUCT & DYN OF NICOTINIC ACETYLCHOLINE RECEPTORS:
修改结构
- 批准号:
8362793 - 财政年份:2011
- 资助金额:
$ 53.46万 - 项目类别:
INTEGRATIVE MODEL OF SUBCELL PROCESSES: APPL TO SYNAPTIC ACT & PHARM DISCOVERY
子细胞过程的整合模型:应用于突触行为
- 批准号:
7955219 - 财政年份:2009
- 资助金额:
$ 53.46万 - 项目类别:
INTEGRATIVE MODEL OF SUBCELL PROCESSES: APPL TO SYNAPTIC ACT & PHARM DISCOVERY
子细胞过程的整合模型:应用于突触行为
- 批准号:
7722292 - 财政年份:2008
- 资助金额:
$ 53.46万 - 项目类别:
ASSOCIATION OF ELONGATION FACTORS AND ANTIBIOTICS WITH THE RIBOSOME
延伸因子和抗生素与核糖体的关联
- 批准号:
7173057 - 财政年份:2006
- 资助金额:
$ 53.46万 - 项目类别:
ASSOCIATION OF ELONGATION FACTORS AND ANTIBIOTICS WITH THE RIBOSOME
延伸因子和抗生素与核糖体的关联
- 批准号:
7537241 - 财政年份:2006
- 资助金额:
$ 53.46万 - 项目类别:
相似海外基金
Effect of Acetylcholinesterase inhibitors on Bone Metabolism and Fracture Risk Factors among older adults with mild to moderate Alzheimer's Disease
乙酰胆碱酯酶抑制剂对患有轻至中度阿尔茨海默病的老年人骨代谢和骨折危险因素的影响
- 批准号:
10739853 - 财政年份:2023
- 资助金额:
$ 53.46万 - 项目类别:
Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
- 批准号:
10772738 - 财政年份:2023
- 资助金额:
$ 53.46万 - 项目类别:
Machine learning approaches to predict Acetylcholinesterase inhibition
预测乙酰胆碱酯酶抑制的机器学习方法
- 批准号:
10378934 - 财政年份:2021
- 资助金额:
$ 53.46万 - 项目类别:
Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
- 批准号:
10303546 - 财政年份:2021
- 资助金额:
$ 53.46万 - 项目类别:
Investigating the in vivo targets and mechanism of action of a toxic acetylcholinesterase-derived peptide upregulated in Alzheimer's disease
研究阿尔茨海默病中上调的有毒乙酰胆碱酯酶衍生肽的体内靶点和作用机制
- 批准号:
2480200 - 财政年份:2020
- 资助金额:
$ 53.46万 - 项目类别:
Studentship
Improved Therapeutics for the Resurrection of the Aged Form of Acetylcholinesterase
老化乙酰胆碱酯酶复活的改进疗法
- 批准号:
9977281 - 财政年份:2019
- 资助金额:
$ 53.46万 - 项目类别:
Improved Therapeutics for the Resurrection of the Aged Form of Acetylcholinesterase
老化乙酰胆碱酯酶复活的改进疗法
- 批准号:
10238898 - 财政年份:2019
- 资助金额:
$ 53.46万 - 项目类别:
Elucidation of the cell protective mechanism of acetylcholinesterase variants in cardiomyocyte and approach to therapy for myocardial infarction
心肌细胞乙酰胆碱酯酶变异体的细胞保护机制的阐明及心肌梗死的治疗方法
- 批准号:
18K15850 - 财政年份:2018
- 资助金额:
$ 53.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Alzheimer's disease drugs inhibiting acetylcholinesterase on prion replication.
阿尔茨海默病药物抑制乙酰胆碱酯酶对朊病毒复制的影响。
- 批准号:
481759-2015 - 财政年份:2015
- 资助金额:
$ 53.46万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Reactivation of Aged Acetylcholinesterase: Design and Development of Novel Therap
老化乙酰胆碱酯酶的重新激活:新型疗法的设计和开发
- 批准号:
8735550 - 财政年份:2014
- 资助金额:
$ 53.46万 - 项目类别: